The same can be said for SCFD1, which has only been recently identified as a risk locus [13], and for which we report a damaging variant in an ALS patient with a young age of onset (27 years) and whose disease progression is exceptionally slow. This evidence concerns the gene SCFD1 and amyotrophic lateral sclerosis.